1NisanevichV, FelsensteinI,AlmogyG,etal.Effect of intraopera- tive fluid management on outcome after intraabdominalsurgery[J]. Anesthesiology,2005,103(1):25-32.
5Thomas A.Neff MD,Martin D,et al.Repetitive Large_Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in patients with severe head injury[J].nesth Analg,2003,96(5):1453-1459.
8Gerd Haisch,MD,Joachirn Boldt,MD,et al.The influence of in travascular volume therapy with a new hydroxyethyl starch prepa- ration(6%HES130/0.4) on coagulation in patients undergoing major abdominal surgery[J].Anesth Analg,2001,92(3):565-571.
3Hankeln K, Beez M. Haemodynamic and oxygen transport collelates of various volume substitutes in critically ill in-patients with various aetiologies of haemodynamic instability. Inter J Intensive Care 1998; 5: 8.
4McIlroy DR, Kharasch ED. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia[J]. Anesth Analg,2003, 96(6): 1572-1577.
5Fakhry SM. Hematologic principles in surgery. In:Sabiston:Textbook[M]. 16th Ed. Philadelphia: W.B.Saunders Company. 2001.68.
6Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials[J]. BMJ, 1998, 317(7153): 235-240.
7Allison SP, Lobo DN. Debate: Albumin administration should not be avoided[J]. Crit Care, 2000, 4(3): 147-150.
8Boldt J,Muller M, Mentges D, et al. Volume therapy in the critically ill: is there a difference[J]? Intensive Care Med, 1998,24(1):28-36.
